General Surgery Devices are used in diagnostic and surgical interventions primarily for the gastrointestinal tract, abdomen, and pelvis. An Airway Stent is a hollow tube shaped device which is inserted into an airway to relieve obstruction. GlobalData uses proprietary data and analytics to provide a comprehensive report on the airway stents devices market, including market shares of different players within India. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the airway stents market in India was Atrium Medical followed by Boston Scientific, Merit Medical Systems, Micro-Tech Nanjing, Cook Medical and Lymol Medical.
An Airway Stent is also known as a tracheobronchial stent. Metallic Airway Stents and Silicone Airway Stents are the devices tracked under Airway Stent. Metallic Airway Stent are mainly referred as the Self Expandable Metallic Stents (SEMS) which are composed of metallic mesh wires and most of the SEMS are not used in non-malignant disorders. A Silicone Airway Stent is made from medical grade silicone with studs on the external surface.
The value of the airway stents devices market within India was expected to be over $0.5m in 2023.
For the latest complete market share analysis of airway stents device market in India, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
